BioElectronics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Revenue	1.61	0.83	0.94	1.05	1.76
Revenue Growth (YoY)	94.01%	-11.91%	-9.96%	-40.70%	-15.60%
Cost of Revenue	0.81	0.32	0.41	0.69	0.77
Gross Profit	0.8	0.51	0.53	0.36	1
Selling, General & Admin	0.6	1.04	1.12	1.8	1.88
Research & Development	0.33	0.48	0.66	0.5	0.39
Operating Expenses	0.93	1.54	1.84	2.37	2.29
Operating Income	-0.14	-1.03	-1.31	-2.01	-1.3
Interest Expense	-0.31	-0.26	-0.99	-0.95	-0.76
Other Non Operating Income (Expenses)	-0.08	0.14	-0.03	-0.03	-0.06
EBT Excluding Unusual Items	-0.53	-1.16	-2.33	-2.99	-2.12
Other Unusual Items	0.24	-	-	-	-
Pretax Income	-0.29	-1.16	-2.33	-2.99	-2.12
Net Income	-0.29	-1.16	-2.33	-2.99	-2.12
Net Income to Common	-0.29	-1.16	-2.33	-2.99	-2.12
Shares Outstanding (Basic)	24,257	23,526	21,812	19,849	16,979
Shares Outstanding (Diluted)	24,257	23,526	21,812	19,849	16,979
Shares Change (YoY)	3.11%	7.86%	9.89%	16.91%	32.23%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00
Free Cash Flow	-0.32	-0.53	-0.72	-1.35	-0.87
Gross Margin	49.43%	61.02%	56.24%	34.17%	56.59%
Operating Margin	-8.52%	-124.50%	-138.68%	-192.19%	-73.52%
Profit Margin	-18.01%	-139.80%	-246.91%	-285.73%	-120.13%
Free Cash Flow Margin	-19.90%	-63.65%	-75.99%	-129.31%	-49.26%
EBITDA	-	-1.03	-1.31	-2.01	-1.29
EBITDA Margin	-	-124.40%	-138.59%	-191.97%	-73.39%
D&A For EBITDA	-	0	0	0	0
EBIT	-0.14	-1.03	-1.31	-2.01	-1.3
EBIT Margin	-8.52%	-124.50%	-138.68%	-192.19%	-73.52%
Advertising Expenses	-	-	0	0.14	-